Kasvu Therapeutics
PrivateLast Round
Seed
Sep 1, 2024
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kasvu Therapeutics is a biotechnology company that develops non-hallucinogenic small molecule neuroplastogens for the treatment of neuropsychiatric and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kasvu Therapeutics Comparables
Compare Kasvu Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delix Therapeutics | 87% | |
| Elkedonia | 83% | |
| Xylo Bio | 83% | |
Kasvu Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 1, 2024 |
Kasvu Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nordic Science Investments | Seed |
| Innovestor | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
Monthly visitors increased 561% from 82 to 542.
- Jun 4, 2025
Grew 100% QoQ from 5 to 10 employees.
Kasvu Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kasvu Therapeutics's valuation, stock price, and market status.